Cost-effectiveness of hepatitis A vaccine in prevention of secondary hepatitis A infection

被引:13
|
作者
Péchevis, M
Khoshnood, B
Buteau, L
Durand, I
Piquard, Y
Lafuma, A
机构
[1] EVAL, CEMKA, F-92340 Bourg La Reine, France
[2] GlaxoSmithKline, F-78163 Marly Le Roi, France
关键词
hepatitis A vaccine; secondary prevention; cost-effectiveness analysis;
D O I
10.1016/S0264-410X(03)00424-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Using a decision-tree based model, we investigated the cost-effectiveness of several vaccination strategies for household, day care center and nursery/primary school contacts of primary cases of hepatitis A in France. Depending on the age groups vaccinated, the cost per symptomatic case avoided varied between Euro 700 and 1300 ( Euro 1 = US$ 0.93) for household contacts. Vaccination of contacts in day care centers and schools resulted in cost-savings. However, these findings are contingent on the limited and controversial data available on vaccine protective efficacy. In particular, the question of the relative efficacy of vaccination as compared with the use of immunoglobulins needs further study. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3556 / 3564
页数:9
相关论文
共 50 条
  • [41] The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique
    Griffiths, UK
    Hutton, G
    Pascoal, ED
    [J]. HEALTH POLICY AND PLANNING, 2005, 20 (01) : 50 - 59
  • [42] Long-term effectiveness and cost-effectiveness of screening for Hepatitis C virus infection
    Sroczynski, Gaby
    Esteban, Eva
    Conrads-Frank, Annette
    Schwarzer, Ruth
    Muehlberger, Nikolai
    Wright, Davene
    Zeuzem, Stefan
    Siebert, Uwe
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2009, 19 (03): : 245 - 253
  • [43] Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C - Reply
    Myers, RP
    Gregor, JC
    Marotta, PJ
    [J]. HEPATOLOGY, 2000, 32 (04) : 874 - 875
  • [44] The cost-effectiveness of two strategies for vaccinating US veterans with hepatitis C virus infection against hepatitis A and hepatitis B viruses
    Jakiche, Rita
    Borrego, Matthew E.
    Raisch, Dennis W.
    Gupchup, Gireesh V.
    Pai, Manjunath A.
    Jakiche, Antoine
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2007, 333 (01): : 26 - 34
  • [45] The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis
    Jacobs, RJ
    Koff, RS
    Meyerhoff, AS
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (02): : 427 - 434
  • [46] Prevention of hepatitis A with the hepatitis A vaccine
    Craig, AS
    Schaffner, W
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (05): : 476 - 481
  • [47] Cost-effectiveness of hepatitis A-B vaccine versus hepatitis B vaccine for healthcare and public safety workers in the western United States
    Jacobs, RJ
    Gibson, GA
    Meyerhoff, AS
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2004, 25 (07): : 563 - 569
  • [48] Cost-effectiveness of hepatitis A vaccination for adults in Belgium
    Luyten, Jeroen
    Van de Sande, Stefaan
    de Schrijver, Koen
    Van Damme, Pierre
    Beutels, Philippe
    [J]. VACCINE, 2012, 30 (42) : 6070 - 6080
  • [49] Cost-effectiveness of treatment for chronic hepatitis C
    Koff, RS
    [J]. JOURNAL OF HEPATOLOGY, 1999, 31 : 255 - 258
  • [50] Cost-effectiveness of interferon treatment for hepatitis C
    van Leeuwen, DJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (22): : 2083 - 2084